Literature DB >> 26702834

A Negative Regulatory Mechanism Involving 14-3-3ζ Limits Signaling Downstream of ROCK to Regulate Tissue Stiffness in Epidermal Homeostasis.

Jasreen Kular1, Kaitlin G Scheer1, Natasha T Pyne1, Amr H Allam2, Anthony N Pollard1, Astrid Magenau2, Rebecca L Wright1, Natasha Kolesnikoff1, Paul A Moretti1, Lena Wullkopf2, Frank C Stomski1, Allison J Cowin3, Joanna M Woodcock1, Michele A Grimbaldeston4, Stuart M Pitson4, Paul Timpson2, Hayley S Ramshaw4, Angel F Lopez4, Michael S Samuel5.   

Abstract

ROCK signaling causes epidermal hyper-proliferation by increasing ECM production, elevating dermal stiffness, and enhancing Fak-mediated mechano-transduction signaling. Elevated dermal stiffness in turn causes ROCK activation, establishing mechano-reciprocity, a positive feedback loop that can promote tumors. We have identified a negative feedback mechanism that limits excessive ROCK signaling during wound healing and is lost in squamous cell carcinomas (SCCs). Signal flux through ROCK was selectively tuned down by increased levels of 14-3-3ζ, which interacted with Mypt1, a ROCK signaling antagonist. In 14-3-3ζ(-/-) mice, unrestrained ROCK signaling at wound margins elevated ECM production and reduced ECM remodeling, increasing dermal stiffness and causing rapid wound healing. Conversely, 14-3-3ζ deficiency enhanced cutaneous SCC size. Significantly, inhibiting 14-3-3ζ with a novel pharmacological agent accelerated wound healing 2-fold. Patient samples of chronic non-healing wounds overexpressed 14-3-3ζ, while cutaneous SCCs had reduced 14-3-3ζ. These results reveal a novel 14-3-3ζ-dependent mechanism that negatively regulates mechano-reciprocity, suggesting new therapeutic opportunities.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  14-3-3ζ; MYPT; ROCK; RhoA; RhoC; mechano-reciprocity; mechano-transduction; re-epithelialization; wound healing

Mesh:

Substances:

Year:  2015        PMID: 26702834     DOI: 10.1016/j.devcel.2015.11.026

Source DB:  PubMed          Journal:  Dev Cell        ISSN: 1534-5807            Impact factor:   12.270


  16 in total

Review 1.  Mechano-reciprocity is maintained between physiological boundaries by tuning signal flux through the Rho-associated protein kinase.

Authors:  Sarah T Boyle; Michael S Samuel
Journal:  Small GTPases       Date:  2016-05-11

Review 2.  Charting the unexplored extracellular matrix in cancer.

Authors:  Elysse C Filipe; Jessica L Chitty; Thomas R Cox
Journal:  Int J Exp Pathol       Date:  2018-04-19       Impact factor: 1.925

3.  Transient tissue priming via ROCK inhibition uncouples pancreatic cancer progression, sensitivity to chemotherapy, and metastasis.

Authors:  Claire Vennin; Venessa T Chin; Sean C Warren; Morghan C Lucas; David Herrmann; Astrid Magenau; Pauline Melenec; Stacey N Walters; Gonzalo Del Monte-Nieto; James R W Conway; Max Nobis; Amr H Allam; Rachael A McCloy; Nicola Currey; Mark Pinese; Alice Boulghourjian; Anaiis Zaratzian; Arne A S Adam; Celine Heu; Adnan M Nagrial; Angela Chou; Angela Steinmann; Alison Drury; Danielle Froio; Marc Giry-Laterriere; Nathanial L E Harris; Tri Phan; Rohit Jain; Wolfgang Weninger; Ewan J McGhee; Renee Whan; Amber L Johns; Jaswinder S Samra; Lorraine Chantrill; Anthony J Gill; Maija Kohonen-Corish; Richard P Harvey; Andrew V Biankin; T R Jeffry Evans; Kurt I Anderson; Shane T Grey; Christopher J Ormandy; David Gallego-Ortega; Yingxiao Wang; Michael S Samuel; Owen J Sansom; Andrew Burgess; Thomas R Cox; Jennifer P Morton; Marina Pajic; Paul Timpson
Journal:  Sci Transl Med       Date:  2017-04-05       Impact factor: 17.956

4.  Systemic Delivery of Anti-Integrin αL Antibodies Reduces Early Macrophage Recruitment, Inflammation, and Scar Formation in Murine Burn Wounds.

Authors:  Xanthe L Strudwick; Damian H Adams; Natasha T Pyne; Michael S Samuel; Rachael Z Murray; Allison J Cowin
Journal:  Adv Wound Care (New Rochelle)       Date:  2020-01-28       Impact factor: 4.730

Review 5.  Targeting ROCK activity to disrupt and prime pancreatic cancer for chemotherapy.

Authors:  Claire Vennin; Nicola Rath; Marina Pajic; Michael F Olson; Paul Timpson
Journal:  Small GTPases       Date:  2017-10-03

6.  Epidermal ROCK2 induces AKT1/GSK3β/β-catenin, NFκB and dermal tenascin C; but enhanced differentiation and p53/p21 inhibit papilloma.

Authors:  Siti F Masre; Nicola Rath; Michael F Olson; David A Greenhalgh
Journal:  Carcinogenesis       Date:  2020-10-15       Impact factor: 4.944

7.  ROCK-mediated selective activation of PERK signalling causes fibroblast reprogramming and tumour progression through a CRELD2-dependent mechanism.

Authors:  Sarah Theresa Boyle; Valentina Poltavets; Jasreen Kular; Natasha Theresa Pyne; Jarrod John Sandow; Alexander Charles Lewis; Kendelle Joan Murphy; Natasha Kolesnikoff; Paul Andre Bartholomew Moretti; Melinda Nay Tea; Vinay Tergaonkar; Paul Timpson; Stuart Maxwell Pitson; Andrew Ian Webb; Robert John Whitfield; Angel Francisco Lopez; Marina Kochetkova; Michael Susithiran Samuel
Journal:  Nat Cell Biol       Date:  2020-05-25       Impact factor: 28.824

Review 8.  Intravital imaging reveals new ancillary mechanisms co-opted by cancer cells to drive tumor progression.

Authors:  Claire Vennin; David Herrmann; Morghan C Lucas; Paul Timpson
Journal:  F1000Res       Date:  2016-05-16

9.  Three-dimensional organotypic matrices from alternative collagen sources as pre-clinical models for cell biology.

Authors:  James R W Conway; Claire Vennin; Aurélie S Cazet; David Herrmann; Kendelle J Murphy; Sean C Warren; Lena Wullkopf; Alice Boulghourjian; Anaiis Zaratzian; Andrew M Da Silva; Marina Pajic; Jennifer P Morton; Thomas R Cox; Paul Timpson
Journal:  Sci Rep       Date:  2017-12-04       Impact factor: 4.379

10.  Positive regulatory interactions between YAP and Hedgehog signalling in skin homeostasis and BCC development in mouse skin in vivo.

Authors:  Bassem Akladios; Veronica Mendoza Reinoso; Jason E Cain; Taopeng Wang; Duncan L Lambie; D Neil Watkins; Annemiek Beverdam
Journal:  PLoS One       Date:  2017-08-18       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.